The Alarming Health and Economic Crisis Facing Families and Governments

The U.S. faces a looming financial and healthcare crisis as Alzheimer’s and related dementias outpace cancer and heart disease in economic impact, with costs expected to rise from $345 billion in 2023 to $1.5 trillion by 2050—nearly doubling per capita spending on long-term care.

According to a June 2026 report by the Alzheimer’s Association, the disease’s economic burden now exceeds that of cancer and heart disease combined, with families and governments bearing the brunt of rising care costs. “People should be alarmed,” said Dr. Maria Carrillo, chief scientific officer of the Alzheimer’s Association. “This is a health crisis. It’s also an economic crisis for families and government.”

"This is a health crisis. It’s also an economic crisis for families and government."
—Dr. Maria Carrillo, Alzheimer’s Association

The report projects that by 2050, the number of Americans living with Alzheimer’s will reach 13.8 million, up from 6.9 million in 2023. Medicaid and Medicare already cover nearly two-thirds of dementia-related costs, but the system is under strain. Nursing home care alone averages $100,000 per year per resident, while in-home care for dementia patients costs families an average of $60,000 annually—a figure that excludes unpaid caregiving, which the AARP estimates at $273 billion in lost wages and productivity.

Why is Alzheimer’s care more expensive than cancer or heart disease?
The Alzheimer’s Association attributes the cost surge to three factors: the disease’s relentless progression, the lack of a cure, and the intensive long-term care required. Unlike cancer or heart disease, which may respond to treatment, Alzheimer’s demands round-the-clock supervision, often in specialized facilities. A 2025 study in The Lancet found that dementia patients spend an average of 4.5 years in long-term care before death—nearly twice the duration of cancer patients.

How are governments responding?
The Biden administration’s 2026 budget includes $4.5 billion for Alzheimer’s research, up from $3.3 billion in 2023, but advocates argue funding remains insufficient. Meanwhile, states like California and New York have expanded Medicaid waivers for home-based dementia care, though eligibility gaps persist. A June 2026 Kaiser Family Foundation analysis found that 40% of states still impose asset tests or waiting periods for Medicaid long-term care, leaving many families financially exposed.

What happens next for families and caregivers?
The economic pressure is already visible. A 2026 survey by the National Alliance for Caregiving found that 60% of unpaid caregivers report financial strain, with 30% dipping into retirement savings to cover costs. The Alzheimer’s Association warns that without systemic change, the crisis will deepen: by 2040, unpaid caregiving hours could exceed 20 billion annually, equivalent to the labor of 1.3 million full-time workers.

How does this compare to other chronic diseases?
While cancer and heart disease receive more research funding—$7.8 billion and $5.3 billion in NIH grants, respectively—the Alzheimer’s Association notes that per-patient spending on dementia care is 2.3 times higher than for cancer. A 2025 JAMA Network Open study highlighted that heart disease patients often recover enough to return to work, whereas dementia patients rarely do, amplifying the economic toll.

What’s the outlook for insurance and long-term care?
Private long-term care insurance remains rare, with only 7.5% of Americans holding policies, per the American Association for Long-Term Care Insurance. Medicaid remains the primary safety net, but its sustainability is questioned as baby boomers age. The Alzheimer’s Association projects that by 2030, Medicaid spending on dementia will consume 15% of its total budget—a level that could force states to cut other services.

Experts say the crisis demands policy shifts, including expanded home-care subsidies, workplace protections for caregivers, and accelerated drug development. “We’re at a tipping point,” said Carrillo. “The question is whether we act now—or pay the price later.”